On September 17, British American Tobacco (BAT) launched a report resource called "Omni™" on its official website.
According to BAT, The Omni™ is mainly aimed at scientists, public health organizations, regulators, policymakers, and investors. It gathers the latest progress made by BAT in Tobacco Harm Reduction, with the goal of helping adult smokers transition to smoke-free alternatives by providing products with lower risks compared to traditional cigarettes.
The "Omni™" report consists of nine chapters, discussing key issues related to tobacco harm reduction and providing evidence from the past decade of global efforts to reduce tobacco-related harm.
BAT has stated that its goal is to have 50 million new tobacco product users by 2030, with the revenue from these products accounting for 50% by 2035.
At the same time, BAT also acknowledges that in the process of promoting a smoke-free world, they face many challenges, including opposition from regulatory agencies and non-governmental organizations, market sales restrictions, heavy regulatory frameworks, industry research being questioned, and public misunderstandings about the risks of nicotine and smoke-free products. The company emphasizes that it will continue to reduce the health risks of traditional tobacco products through science and innovation.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
